Laura L. Read

839 total citations
24 papers, 631 citations indexed

About

Laura L. Read is a scholar working on Molecular Biology, Physiology and General Health Professions. According to data from OpenAlex, Laura L. Read has authored 24 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Physiology and 4 papers in General Health Professions. Recurrent topics in Laura L. Read's work include Metabolism and Genetic Disorders (4 papers), Smoking Behavior and Cessation (3 papers) and Diet and metabolism studies (3 papers). Laura L. Read is often cited by papers focused on Metabolism and Genetic Disorders (4 papers), Smoking Behavior and Cessation (3 papers) and Diet and metabolism studies (3 papers). Laura L. Read collaborates with scholars based in United States, United Kingdom and Italy. Laura L. Read's co-authors include James D. Clelland, Murray E. Jarvik, Catherine L. Clelland, Mary Richardson, Nina Schneider, Alan B. Forsythe, Mark L. Elliott, Avraham Schweiger, Helen M. Chao and Raymond F. Suckow and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Laura L. Read

22 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura L. Read United States 16 262 176 101 82 72 24 631
Bryan Shapiro United States 12 139 0.5× 86 0.5× 106 1.0× 56 0.7× 106 1.5× 25 733
Calum D. Moulton United Kingdom 14 177 0.7× 119 0.7× 149 1.5× 68 0.8× 192 2.7× 36 1.1k
Maria Teresa Cruz Lourenço Canada 12 152 0.6× 99 0.6× 177 1.8× 50 0.6× 86 1.2× 19 552
Philippe Batel France 15 222 0.8× 281 1.6× 159 1.6× 60 0.7× 35 0.5× 41 1.2k
Chun‐Hsin Chen Taiwan 13 146 0.6× 200 1.1× 94 0.9× 22 0.3× 194 2.7× 33 543
Sydney Frederick United States 6 301 1.1× 151 0.9× 24 0.2× 70 0.9× 25 0.3× 6 618
M. Soledad Cepeda United States 14 177 0.7× 70 0.4× 99 1.0× 119 1.5× 90 1.3× 34 684
Brigitte Vanle United States 11 81 0.3× 62 0.4× 95 0.9× 64 0.8× 41 0.6× 20 613
David Babb United States 11 159 0.6× 121 0.7× 120 1.2× 71 0.9× 20 0.3× 13 618
Robert Chapman United Kingdom 10 200 0.8× 130 0.7× 52 0.5× 18 0.2× 56 0.8× 17 708

Countries citing papers authored by Laura L. Read

Since Specialization
Citations

This map shows the geographic impact of Laura L. Read's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura L. Read with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura L. Read more than expected).

Fields of papers citing papers by Laura L. Read

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura L. Read. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura L. Read. The network helps show where Laura L. Read may publish in the future.

Co-authorship network of co-authors of Laura L. Read

This figure shows the co-authorship network connecting the top 25 collaborators of Laura L. Read. A scholar is included among the top collaborators of Laura L. Read based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura L. Read. Laura L. Read is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kennedy, James, Daniel J. Blackman, Matthew Dodd, et al.. (2025). Impact of Cerebral Embolic Protection on Cognitive Function After Transcatheter Aortic Valve Implantation: Data From the BHF PROTECT-TAVI Randomized Trial. Circulation. 152(18). 1268–1278.
2.
Kennedy, James, Matthew C. Dodd, Laura L. Read, et al.. (2025). Accommodating Asymmetric Adherence in Clinical Trial Analyses. Journal of the American College of Cardiology. 86(11). 829–831.
3.
Read, Laura L., et al.. (2019). Trigger finger. JAAPA. 32(1). 17–21. 31 indexed citations
4.
Read, Laura L., et al.. (2019). Opioid use disorder during pregnancy. JAAPA. 32(3). 20–24. 1 indexed citations
5.
Clelland, James D., et al.. (2018). Regulation of cortical and peripheral GCH1 expression and biopterin levels in schizophrenia-spectrum disorders. Psychiatry Research. 262. 229–236. 7 indexed citations
6.
Clelland, Catherine L., et al.. (2016). Evidence that COMT genotype and proline interact on negative-symptom outcomes in schizophrenia and bipolar disorder. Translational Psychiatry. 6(9). e891–e891. 21 indexed citations
7.
Clelland, James D., et al.. (2014). Vitamin D insufficiency and schizophrenia risk: Evaluation of hyperprolinemia as a mediator of association. Schizophrenia Research. 156(1). 15–22. 26 indexed citations
8.
Clelland, Catherine L., et al.. (2013). Utilization of Never-Medicated Bipolar Disorder Patients towards Development and Validation of a Peripheral Biomarker Profile. PLoS ONE. 8(6). e69082–e69082. 25 indexed citations
9.
Clelland, Catherine L., et al.. (2011). Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome. Schizophrenia Research. 131(1-3). 139–145. 52 indexed citations
10.
Richardson, Mary, Helen M. Chao, Laura L. Read, James D. Clelland, & Raymond F. Suckow. (2006). Investigation of the phenylalanine hydroxylase gene and tardive dyskinesia. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 141B(2). 195–197. 3 indexed citations
11.
Richardson, Mary, Laura L. Read, Margaret A. Reilly, James D. Clelland, & Catherine L. Clelland. (2006). Analysis of Plasma Biopterin Levels in Psychiatric Disorders Suggests a Common BH4 Deficit in Schizophrenia and Schizoaffective Disorder. Neurochemical Research. 32(1). 107–113. 40 indexed citations
12.
Richardson, Mary, Laura L. Read, Catherine L. Clelland, et al.. (2005). Evidence for a Tetrahydrobiopterin Deficit in Schizophrenia. Neuropsychobiology. 52(4). 190–201. 33 indexed citations
13.
Richardson, Mary, Arthur M. Small, Laura L. Read, Helen M. Chao, & James D. Clelland. (2004). Branched Chain Amino Acid Treatment of Tardive Dyskinesia in Children and Adolescents. The Journal of Clinical Psychiatry. 65(1). 92–96. 24 indexed citations
14.
Richardson, Mary, Laura L. Read, James D. Clelland, et al.. (2003). Phenylalanine hydroxylase gene in psychiatric patients: screening and functional assay of mutations. Biological Psychiatry. 53(6). 543–553. 15 indexed citations
15.
Richardson, Mary, Margaret Bevans, Laura L. Read, et al.. (2003). Efficacy of the Branched-Chain Amino Acids in the Treatment of Tardive Dyskinesia in Men. American Journal of Psychiatry. 160(6). 1117–1124. 41 indexed citations
16.
Read, Laura L., et al.. (1999). Pharmacy-Based Evaluation and Treatment of Minor Illnesses in a Culturally Diverse Pediatric Clinic. Archives of Pediatrics and Adolescent Medicine. 153(7). 731–731. 15 indexed citations
17.
Richardson, Mary, Margaret A. Reilly, Laura L. Read, et al.. (1999). Phenylalanine kinetics are associated with tardive dyskinesia in men but not in women. Psychopharmacology. 143(4). 347–357. 6 indexed citations
18.
Berman, Barbara, Laura L. Read, Alfred C. Marcus, & Ellen R. Gritz. (1992). Nurses Enrolled in a Stop Smoking Program: The Role of Occupational Stress. Journal of women's health. 1(1). 41–46. 8 indexed citations
19.
Gritz, Ellen R., Barbara Berman, Laura L. Read, Alfred C. Marcus, & Jessie Siau. (1990). Weight Change among Registered Nurses in a Self-Help Smoking Cessation Program. American Journal of Health Promotion. 5(2). 115–121. 17 indexed citations
20.
Schneider, Nina, Murray E. Jarvik, Alan B. Forsythe, et al.. (1983). Nicotine gum in smoking cessation: A placebo-controlled, double-blind trial. Addictive Behaviors. 8(3). 253–261. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryan Shapiro Breakdown of academic impact, for papers by Calum D. Moulton Breakdown of academic impact, for papers by Maria Teresa Cruz Lourenço Breakdown of academic impact, for papers by Philippe Batel Breakdown of academic impact, for papers by Chun‐Hsin Chen Breakdown of academic impact, for papers by Sydney Frederick Breakdown of academic impact, for papers by M. Soledad Cepeda Breakdown of academic impact, for papers by Brigitte Vanle Breakdown of academic impact, for papers by David Babb Breakdown of academic impact, for papers by Robert Chapman
Rankless by CCL
2026